Oneness Biotech Co., Ltd. (TPEX:4743)
57.30
-1.60 (-2.72%)
Nov 21, 2025, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 27.4 billion as of November 21, 2025. Its market cap has decreased by -56.00% in one year.
Market Cap
27.40B
Enterprise Value
22.38B
Revenue
117.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.30
Market Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 27.40B, an increase of 2,110.49%. That is a compound annual growth rate of 20.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 27.40B | -34.25% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | 89.76B | 772.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 189.99B |
| PharmaEssentia | 167.73B |
| Lotus Pharmaceutical | 74.42B |
| Bora Pharmaceuticals Co., LTD. | 65.56B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 26.91B |
| Pegavision | 24.69B |
| Polaris Group | 22.54B |